Skip to main content
Loading

Reducing systemic toxicity following release of cytotoxic drugs after internalization and cleavage of the linker harming normal tissues expressing low levels of the target antigen

18 Jun 2025
Toxicity & Off-Target Effects
Industry Expert
Kyle Fitzgerald, Associate Director - Mythic Therapeutics